Clemens A. Schmitt

16.2k total citations · 5 hit papers
110 papers, 7.0k citations indexed

About

Clemens A. Schmitt is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Clemens A. Schmitt has authored 110 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 49 papers in Oncology and 26 papers in Physiology. Recurrent topics in Clemens A. Schmitt's work include Telomeres, Telomerase, and Senescence (26 papers), Cancer-related Molecular Pathways (17 papers) and CAR-T cell therapy research (12 papers). Clemens A. Schmitt is often cited by papers focused on Telomeres, Telomerase, and Senescence (26 papers), Cancer-related Molecular Pathways (17 papers) and CAR-T cell therapy research (12 papers). Clemens A. Schmitt collaborates with scholars based in Germany, Austria and United States. Clemens A. Schmitt's co-authors include Scott W. Lowe, Soyoung Lee, Melanie Braig, Jordan S. Fridman, Robert M. Hoffman, Meng Yang, Eugene Baranov, Bernd Dörken, Marco Demaria and Boshi Wang and has published in prestigious journals such as Nature, Cell and Journal of Clinical Investigation.

In The Last Decade

Clemens A. Schmitt

104 papers receiving 6.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oncogene-induced senescence as an initial barrier in lymphoma development

2005 969 citations Melanie Braig, Soyoung Lee et al. Nature profile →
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy

2002 843 citations Clemens A. Schmitt, Jordan S. Fridman et al. profile →
Senescence and cancer — role and therapeutic opportunities

2022 481 citations Clemens A. Schmitt, Boshi Wang et al. Nature Reviews Clinical Oncology profile →
The dynamic nature of senescence in cancer

2018 421 citations Soyoung Lee, Clemens A. Schmitt Nature Cell Biology profile →
Cellular senescence: Neither irreversible nor reversible

2024 49 citations Maurice Reimann, Soyoung Lee et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Clemens A. Schmitt Germany	36	4.3k	2.4k	2.0k	1.2k	1.0k	110	7.0k
Manuel Collado Spain	34	5.8k 1.3×	2.4k 1.0×	3.2k 1.6×	1.5k 1.3×	1.4k 1.3×	78	9.2k
Thomas Kuilman Netherlands	16	3.8k 0.9×	1.9k 0.8×	2.7k 1.3×	1.4k 1.2×	1.2k 1.1×	25	6.7k
Asha S. Multani United States	40	5.0k 1.2×	3.3k 1.3×	1.4k 0.7×	803 0.7×	1.9k 1.8×	126	8.2k
Mila E. McCurrach United States	20	7.3k 1.7×	3.6k 1.5×	2.1k 1.0×	1.4k 1.2×	1.3k 1.2×	21	9.6k
Takehiko Kamijo Japan	37	5.1k 1.2×	3.2k 1.3×	805 0.4×	670 0.6×	1.0k 1.0×	114	7.1k
Rugang Zhang United States	51	5.8k 1.3×	2.0k 0.8×	1.4k 0.7×	1.3k 1.1×	1.3k 1.3×	145	8.4k
Sandy Chang United States	46	7.6k 1.8×	3.2k 1.3×	4.9k 2.4×	888 0.8×	1.4k 1.3×	88	11.3k
Cornelius Miething Germany	28	3.0k 0.7×	1.5k 0.6×	809 0.4×	1.2k 1.0×	740 0.7×	68	5.1k
Chrysiis Michaloglou United Kingdom	8	3.3k 0.8×	1.4k 0.6×	2.4k 1.2×	1.1k 1.0×	810 0.8×	12	5.5k
Sam W. Lee United States	48	5.0k 1.2×	2.3k 1.0×	671 0.3×	1.2k 1.0×	1.1k 1.0×	93	7.1k

Countries citing papers authored by Clemens A. Schmitt

Since Specialization

Citations

This map shows the geographic impact of Clemens A. Schmitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clemens A. Schmitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clemens A. Schmitt more than expected).

Fields of papers citing papers by Clemens A. Schmitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clemens A. Schmitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clemens A. Schmitt. The network helps show where Clemens A. Schmitt may publish in the future.

Co-authorship network of co-authors of Clemens A. Schmitt

This figure shows the co-authorship network connecting the top 25 collaborators of Clemens A. Schmitt. A scholar is included among the top collaborators of Clemens A. Schmitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clemens A. Schmitt. Clemens A. Schmitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Cuilan, Bingjie Cui, Weiwei Chen, et al.. (2025). Chronic Stress Stimulates Protumor Macrophage Polarization to Propel Lung Cancer Progression. Cancer Research. 85(13). 2429–2447. 6 indexed citations

Dong, Hongliang, Weiwei Chen, Qian Zhang, et al.. (2023). N6-methyladenine-mediated aberrant activation of the lncRNA SOX2OT-GLI1 loop promotes non-small-cell lung cancer stemness. Cell Death Discovery. 9(1). 149–149. 19 indexed citations

Rues, Stefan, et al.. (2023). Effect of firing time and wall thickness on the biaxial flexural strength of 3D-printed zirconia. Dental Materials. 40(3). 484–492. 4 indexed citations

Schmitt, Clemens A., Boshi Wang, & Marco Demaria. (2022). Senescence and cancer — role and therapeutic opportunities. Nature Reviews Clinical Oncology. 19(10). 619–636. 481 indexed citations breakdown →

Kolesnichenko, Marina, Uta E. Höpken, Eva Kärgel, et al.. (2021). Transcriptional repression of NFKBIA triggers constitutive IKK‐ and proteasome‐independent p65/RelA activation in senescence. The EMBO Journal. 40(6). e104296–e104296. 51 indexed citations

Gampenrieder, Simon Peter, Gabriel Rinnerthaler, Christoph Tinchon, et al.. (2021). Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry. Breast Cancer Research. 23(1). 112–112. 94 indexed citations

Martínez‐Zamudio, Ricardo Iván, Pierre‐François Roux, Lucas Robinson, et al.. (2020). Author Correction: AP-1 imprints a reversible transcriptional programme of senescent cells. Nature Cell Biology. 22(10). 1286–1288. 1 indexed citations

Martínez‐Zamudio, Ricardo Iván, Pierre‐François Roux, Lucas Robinson, et al.. (2020). AP-1 imprints a reversible transcriptional programme of senescent cells. Nature Cell Biology. 22(7). 842–855. 123 indexed citations

Jaeger, Carsten, Hermann Brenner, Jenny Chang‐Claude, et al.. (2018). Non‐invasive metastasis prognosis from plasma metabolites in stage II colorectal cancer patients: The DACHS study. International Journal of Cancer. 145(1). 221–231. 9 indexed citations

10.

Schönlein, Martin, J. Henry M. Däbritz, Dorothy Ngo-Yin Fan, et al.. (2017). Therapy‐Induced Senescence Is a Predictor of Treatment Outcome in Acute Myeloid Leukemia. Blood. 130. 1393–1393. 2 indexed citations

11.

Däbritz, J. Henry M., Yong Yu, Maja Milanovic, et al.. (2016). CD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma. Molecular Cancer Therapeutics. 15(5). 1074–1081. 26 indexed citations

12.

Du, Jing, Martin Neuenschwander, Yong Yu, et al.. (2016). Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma. Blood. 129(1). 71–81. 9 indexed citations

13.

Böck, Barbara C., Ulrike Stein, Clemens A. Schmitt, & Hellmut G. Augustin. (2014). Mouse Models of Human Cancer. Cancer Research. 74(17). 4671–4675. 25 indexed citations

14.

Schmitt, Clemens A., et al.. (2014). Chemotherapy-Induced Senescence Reprograms Lymphoma and Leukemia Cells into Latent Cancer Stem Cells That Are Susceptible to Conceptually Novel Treatments. Blood. 124(21). 4788–4788. 1 indexed citations

15.

Schmitt, Clemens A.. (2006). Cellular senescence and cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1775(1). 5–20. 209 indexed citations

16.

Braig, Melanie, Soyoung Lee, Christoph Loddenkemper, et al.. (2005). Oncogene-induced senescence as an initial barrier in lymphoma development. Nature. 436(7051). 660–665. 969 indexed citations breakdown →

17.

Kahlem, Pascal, Bernd Dörken, & Clemens A. Schmitt. (2004). Cellular senescence in cancer treatment: friend or foe?. Journal of Clinical Investigation. 113(2). 169–174. 95 indexed citations

18.

Schmitt, Clemens A., Jordan S. Fridman, Meng Yang, et al.. (2002). Dissecting p53 tumor suppressor functions in vivo. Cancer Cell. 1(3). 289–298. 392 indexed citations

19.

Schmitt, Clemens A. & Scott W. Lowe. (1999). Apoptosis and therapy. The Journal of Pathology. 187(1). 127–137. 4 indexed citations

20.

Wittig, Bianca M., et al.. (1996). ?(1,3)Fucosyltransferase expression in E-selectin-mediated binding of gastrointestinal tumor cells. International Journal of Cancer. 67(1). 80–85. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact